Euromonitor International’s Senior Research Analyst Alex Esposito interviews Cindy Bryant, Chief Business Officer at Demetrix about the world of cannabinoids beyond THC and CBD. Cindy explains Demetrix’s unique approach to using fermentation to produce cannabinoids and how this differs from predominant production methods. Alex and Cindy also delve into the potential of new cannabinoids other than THC and CBD, ways they can help consumers and how we’re only just beginning to understand the promise of cannabinoids for use in health and wellness. Learn more about Demetrix at their website, and dive into their unique approach to producing cannabinoids their blog.
Nicotine and Cannabis
Explore thought-leadership and expert insights on the consumer behaviour, regulatory forces and cutting-edge innovation trends shaping the complex and rapidly developing nicotine and cannabis industries.
Find content by
Cannabinoids Beyond THC and CBD: An Interview with Cindy Bryant, Chief Business Officer at Demetrix
2/24/2021Explore More
Shop Our Reports
Top Five Trends in Nicotine
This report outlines five forces reshaping the nicotine market: intensifying regulation, reduced visibility of smoking, growth of multi format usage, expanding…
View ReportThe World Market for Nicotine
Global nicotine markets remain structurally stable as declining cigarette volumes are offset by the rise of reduced-risk products such as heated tobacco,…
View ReportBuilding Market Resilience: Applying Crisis Learnings to the Iran War
The 2026 Iran conflict marks the fourth major economic disruption to global consumer markets in under two decades. While each crisis originated differently,…
View Report